By: Benzinga
UPDATE: Oppenheimer Raises PT to $48 on HCA and Reiterates Outperform Rating
Oppenheimer analyst Michael Wiederhorn published a report on HCA Inc. (NYSE: HCA ) that reiterated its Outperform rating and raised the price target from $43 to $48. Oppenheimer reported that, “Our 12- to 18-month price target is $48 per share, or an average of 7x '14E EBITDA of $6.8B, which
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here